Brachytherapy is a very effective treatment for non-metastatic prostate cancer when properly done. Brachytherapy can realize the goal that prostate cancer can be cured nearly 100% as long as the cancer has no metastasis. To achieve this goal, we are conducting quality seed implantation with high radiation dose either by brachytherapy mono-therapy or brachytherapy in combination with external beam radiation therapy (EBRT).
In order to deliver high radiation dose by seed implantation safely, SUMS has a developed method of our own based on Mt. Sinai Medical Center real-time seed implantation technique. Over 850 patients have been treated by brachytherapy at SUMS. So far, PSA relapse free rates (Effectiveness of treatment) at 5 years are 98.3% for low risk patients, 96.9% for intermediate risk patients and 96.3% for high risk patients.